24916-90-3Relevant articles and documents
Preparation method of dexamethasone intermediate
-
Page/Page column 8; 11-18, (2019/03/06)
The invention relates to a preparation method of a dexamethasone intermediate. The preparation method comprises the following steps: adding a Grignard reagent and a silylanizing reagent to carry out aGrignard reaction by taking a compound I as an initial raw material and the compound I as a raw material in the presence of a catalyst to obtain a compound II; adding the compound II into a buffer agent and an oxidizing agent for an epoxidation reaction to obtain a compound III; carrying out a ring-opening reaction on the compound III in an acidic environment to obtain a compound IV; and carryingout a hydrolytic reaction on the compound IV in an alkaline environment to obtain the dexamethasone intermediate V. According to the preparation method, the raw material is easily available, the preparation method is simple, and the intermediates in the steps can be directly applied to next reactions without being purified and separated, so that the preparation method is high in yield and suitable for industrial production.
Process improvements in the synthesis of corticosteroid 9,11β-epoxides
Fu, Xiaoyong,Tann, Chou-Hong,Thiruvengadam
, p. 376 - 382 (2013/09/07)
Corticosteroid 9,11β-epoxides are key intermediates in the preparation of pharmaceutically important compounds such as betamethasone, mometasone, beclomethasone, and dexamethasone. A new process for the 9,11β-epoxide was developed using a PCl5-mediated regioselective dehydration of 11α-hydroxy-steroid to form the corresponding Δ9,11 double bond. The olefin is then converted into 9α,11β-bromoformate by treatment with 1,3-dibromo-5, 5-dimethyl hydantoin (DBH) in DMF and subsequently cyclized to produce the desired 9,11β-epoxide upon treatment with NaOH. Major process-related impurities such as 21-OH-Δ9,11-triene, 21-OH-Δ11,12-triene, 21-Cl-Δ9,11-triene, and β-epoxide-21-cathylate as well as 11β-Cl are all eliminated or minimized. This new process has been implemented in our manufacturing facility in full-scale production and proved to raise the overall yield and the quality of the product dramatically compared to the existing process.
16α-methylatedΔ17(20)-corticoids
-
, (2008/06/13)
C16 -unsaturated corticoids are readily transformed to the corresponding 16α-methyl-17α-hydroxy corticoids by use of a Δ17 (20)-20-silyl ether.